Quick Answer
Summit Therapeutics Inc. reported Gross Profit of -$25.33 million for fiscal year 2019.
Summit Therapeutics Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2019 | -$25.33M | -1047.7% |
| 2019 | $2.67M | +110.3% |
| 2018 | -$25.83M | -3.9% |
| 2017 | -$24.85M | -22.2% |
| 2016 | -$20.35M | — |
- Summit Therapeutics Inc. showed a decrease of -1047.7% in Gross Profit compared to the prior fiscal year.
- Over the 2016–2019 period, Summit Therapeutics Inc.’s gross profit has declined by 24.5% (from -$20.35 million to -$25.33 million).
- The most recent figure is from Summit Therapeutics Inc.’s fiscal year 2019 report (Form 20-F), filed with the SEC on April 30, 2020.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: